Extracorporeal Membrane Oxygenation (ECMO) in Critically Ill Patients with Coronavirus Disease 2019 (COVID-19) Pneumonia and Acute Respiratory Distress Syndrome (ARDS)

Ma, Xiaochun; Liang, Menglin; Ding, Min; Liu, Weiming; Ma, Huibo; Zhou, Xiaoming; Ren, Hongsheng

doi:10.12659/msm.925364

Cited by 70 publications

(50 citation statements)

References 67 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Evidence on the effects of extracorporeal membrane oxygenation in COVID-19 is scant and retrospective (131,(146)(147)(148)(149)(150). The indications in COVID-19 are similar to the indications for other causes of ARDS (151,152), and extracorporeal membrane oxygenation should be considered only after other strategies fail to achieve goals of oxygenation or ventilation (147,148,150).…”

Section: Ventilatory Support For Patients With Copd and Covid-19 Pneumoniamentioning

confidence: 99%

Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease

Halpin

Criner

Papi

et al. 2021

Am J Respir Crit Care Med

567

434

View full text Add to dashboard Cite

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has raised many questions about the management of patients with chronic obstructive pulmonary disease (COPD) and whether modifications of their therapy are required. It has raised questions about recognizing and differentiating coronavirus disease (COVID-19) from COPD given the similarity of the symptoms. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) Science Committee used established methods for literature review to present an overview of the management of patients with COPD during the COVID-19 pandemic. It is unclear whether patients with COPD are at increased risk of becoming infected with SARS-CoV-2. During periods of high community prevalence of COVID-19, spirometry should only be used when it is essential for COPD diagnosis and/or to assess lung function status for interventional procedures or surgery. Patients with COPD should follow basic infection control measures, including social distancing, hand washing, and wearing a mask or face covering. Patients should remain up to date with appropriate vaccinations, particularly annual influenza vaccination. Although data are limited, inhaled corticosteroids, long-acting bronchodilators, roflumilast, or chronic macrolides should continue to be used as indicated for stable COPD management. Systemic steroids and antibiotics should be used in COPD exacerbations according to the usual indications. Differentiating symptoms of COVID-19 infection from chronic underlying symptoms or those of an acute COPD exacerbation may be challenging. If there is suspicion for COVID-19, testing for SARS-CoV-2 should be considered. Patients who developed moderate-to-severe COVID-19, including hospitalization and pneumonia, should be treated with evolving pharmacotherapeutic approaches as appropriate, including remdesivir, dexamethasone, and anticoagulation. Managing acute respiratory failure should include appropriate oxygen supplementation, prone positioning, noninvasive ventilation, and protective lung strategy in patients with COPD and severe acute respiratory distress syndrome. Patients who developed asymptomatic or mild COVID-19 should be followed with the usual COPD protocols. Patients who developed moderate or worse COVID-19 should be monitored more frequently and accurately than the usual patients with COPD, with particular attention to the need for oxygen therapy.

show abstract

Section: Ventilatory Support For Patients With Copd and Covid-19 Pneumoniamentioning

confidence: 99%

Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease

Halpin

Criner

Papi

et al. 2021

Am J Respir Crit Care Med

567

434

View full text Add to dashboard Cite

show abstract

“…Chinese scientists immediately launched emergency research projects to investigate technical means of treating severely ill patients, such as artificial liver and blood purification technologies, to improve the treatment success rate in more severe cases [ 18 ]. In addition, China used a variety of sophisticated medical equipment to combat the pandemic, such as ventilators, extracorporeal membrane oxygenation (ECMO) machines, P3 mobile laboratories, and mobile CT, enabling COVID-19 lung transplant patients who had been on ECMO for the longest duration worldwide, to regain spontaneous breathing [ 19 , 20 ].…”

Section: Central Governmentmentioning

confidence: 99%

Public Health Measures and the Control of COVID-19 in China

Cheng

Zhan

Xue

et al. 2021

Clinic Rev Allerg Immunol

View full text Add to dashboard Cite

In December 2019, the COVID-19 pandemic quickly spread throughout China and beyond, posing enormous global challenges. With prompt, vigorous, and coordinated control measures, mainland China contained the spread of the epidemic within two months and halted the epidemic in three months. Aggressive containment strategy, hierarchical management, rational reallocation of resources, efficient contact tracing, and voluntary cooperation of Chinese citizens contributed to the rapid and efficient control of the epidemic, thus promoting the rapid recovery of the Chinese economy. This review summarizes China’s prevention and control strategies and other public health measures, which may provide a reference for the epidemic control in other countries.

show abstract

“…We also found that bleeding, renal insufficiency, infection, hemolysis, hyperbilirubinemia, and certain circulatory, respiratory and neurological complications are non-mechanical complications. In addition, patients receiving ECMO treatment usually suffer from drug-resistant bacterial infections [4]. There are many methods to perform CRRT during ECMO, which can be divided into three main methods: RRT is performed through venous access that has nothing to do with the ECMO circuit, introduction of a hemofiltration filter into the ECMO circuit using intravenous infusion pumps to control the ultrafiltrate volume and inclusion of a CRRT device in the ECMO circuit [5] (figure 2).…”

Section: Discussionmentioning

confidence: 99%

Continuous renal replacement therapy and ECMO in COVID patients, a Moroccan case report experience

Oujidi¹,

Melhaoui²,

Kherroubi³

et al. 2021

World J. Adv. Res. Rev.

View full text Add to dashboard Cite

Introduction: Extracorporeal membrane oxygenation (ECMO) is a therapy that ameliorate the oxygenation of hypoxemia refractory patient it could be associated to a kidney failure that necessity a Continuous Renal Replacement Therapy. Case Report: We report the case of a 68-year-old patient, who presents ARDS due to covid infection, during his hospitalisation the patient presented a refractory hypoxemia with the need to set up ECMO, the case worsened with kidney failure with need for CRRT. Conclusion: The association between ECMO and CRRT might be a safe and effective technique. A variety of ECMO and CRRT combination methods can be chosen, this remains an association that should be investigated in order to improve the prognosis of kidney failure on ECMO.

show abstract

Extracorporeal Membrane Oxygenation (ECMO) in Critically Ill Patients with Coronavirus Disease 2019 (COVID-19) Pneumonia and Acute Respiratory Distress Syndrome (ARDS)

Cited by 70 publications

References 67 publications

Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease

Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease

Public Health Measures and the Control of COVID-19 in China

Continuous renal replacement therapy and ECMO in COVID patients, a Moroccan case report experience

Contact Info

Product

Resources

About